These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Medical therapy for gastroesophageal reflux disease in 2007. Katz PO Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955 [TBL] [Abstract][Full Text] [Related]
28. [A pilot study on diagnosing laryngopharyngeal reflux disease by pH monitoring in laryngopharynx]. Feng GJ; Zhang LH; Zhao LL; Liu YL Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):805-8. PubMed ID: 18756981 [TBL] [Abstract][Full Text] [Related]
29. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized, sham-controlled trial. Rothstein R; Filipi C; Caca K; Pruitt R; Mergener K; Torquati A; Haber G; Chen Y; Chang K; Wong D; Deviere J; Pleskow D; Lightdale C; Ades A; Kozarek R; Richards W; Lembo A Gastroenterology; 2006 Sep; 131(3):704-12. PubMed ID: 16952539 [TBL] [Abstract][Full Text] [Related]
30. Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095 [TBL] [Abstract][Full Text] [Related]
31. 24-hour esophageal pH monitoring in children with pathological acid gastroesophageal reflux: primary and secondary to food allergy. Part I. Intraesophageal pH values in distal channel; preliminary study and control studies--after 1, 2, 4 and 9 years of clinical observation as well as dietary and pharmacological treatment. Semeniuk J; Kaczmarski M Adv Med Sci; 2007; 52():199-205. PubMed ID: 18217419 [TBL] [Abstract][Full Text] [Related]
33. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Sharma N; Agrawal A; Freeman J; Vela MF; Castell D Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117 [TBL] [Abstract][Full Text] [Related]
34. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study. Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986 [TBL] [Abstract][Full Text] [Related]
35. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients. Weigt J; Kandulski A; Büsch F; Malfertheiner P Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964 [TBL] [Abstract][Full Text] [Related]
36. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501 [TBL] [Abstract][Full Text] [Related]
37. An improved method for detection of gastroesophageal reflux. McAlhany JC; Thomas HF; Woodward ER Surg Forum; 1971; 22():331-3. PubMed ID: 5121394 [No Abstract] [Full Text] [Related]
38. The cumulative incidence of significant gastrooesophageal reflux in patients with oesophageal atresia with a distal fistula--a systematic clinical, pH-metric, and endoscopic follow-up study. Koivusalo A; Pakarinen MP; Rintala RJ J Pediatr Surg; 2007 Feb; 42(2):370-4. PubMed ID: 17270551 [TBL] [Abstract][Full Text] [Related]
40. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Dickman R; Parthasarathy S; Malagon IB; Jones P; Han B; Powers J; Fass R Aliment Pharmacol Ther; 2007 Jul; 26(1):41-8. PubMed ID: 17555420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]